InterWest Partners

InterWest invests an average of about $7 - 15 million over the span of their involvement with each company in their portfolio. They invest in companies through the full range of venture investment stages, and investments may be staged over several rounds of financing. Although they generally begin their involvement in the early stages of a company's development, they pursue attractive opportunities based on their individual merits rather than their investment stage.

Farah Champsi

Managing Partner

Keval Desai

General Partner

Doug Fisher

Executive in Residence

Flip Gianos

General Partner Emeritus

W. Stephen Holmes

General Partner Emeritus

Gil Kliman

Managing Partner

GK

Gilbert Kliman

Managing Partner

Khaled Nasr

General Partner and COO

Arnie Oronsky

Managing Partner

AL

Arnold L. Oronsky

Managing Partner

Michelle Snyder

Advisor

Karen Wilson

CFO

Reza Zadno

Advisor

425 past transactions

Staccato Communications

Series B in 2004
Staccato Communications, Inc. offers ultra wideband wireless enabled devices for the wireless USB, Bluetooth, and Internet protocol connectivity to the personal computing, consumer electronics, and mobile phone industries. Its products include single-chip integrated circuits, device adapter and device module design kits, reference design kits, wireless USB development kits, and streaming services development kits. The company also provides Ripcord Software, which provides a software stack for variety of ultra wide band applications, as well as includes installers, firmware, middleware, drivers, customization tools, and firmware upgrade tools. Staccato Communications’ products are used in various applications, such as printers, camera, mass storage devices, portable media players, wireless docking, wireless projectors, Web cameras, wireless HDTV, wireless speakers, set top boxes, wireless displays, purchasing content, sharing content, and personal servers. Staccato Communications, Inc. was formerly known as Discrete Time Communications, Inc. The company was founded in 2002 and is based in San Diego, California.

PMV Pharmaceutcals

Series A in 2014
PMV Pharma is developing first-in-class p53 and p53 pathway modulators for the treatment of cancer. Bringing together leaders in the field to utilize over three decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus.
The mission of Integrated Diagnostics is to leverage powerful emerging technologies in the development of diagnostic products that enable physicians and patients to manage complex and important diseases such as cancer, diabetes and Alzheimer's through blood tests that can monitor tens to hundreds of disease markers simultaneously. The company plans to develop a pipeline of game-changing diagnostic products that enable the diagnosis and prognosis of a variety of diseases. The company is based on the concept of a systems view of disease where pathophysiology arises from disease-perturbed networks of proteins, genes and other molecules.

The RealReal, Inc.

Series D in 2015
The RealReal, Inc. operates an online marketplace for consigned luxury goods. It offers various resale product categories, including women’s, men’s, kids’, jewelry, and watches, as well as home and art products. The company was founded in 2011 and is headquartered in San Francisco, California.

Badgeville

Series C in 2012
Badgeville is the leading business gamification company with hundreds of global brand customers. With its unique combination of in-app gamification, SaaS platform and big data analytics, Badgeville is building the future of work. The company was founded in 2010 and is headquartered in Silicon Valley. Based in Redwood, CA, the Badgeville team includes experts from Zynga, Playdom, Omniture, Google, Salesforce.com, Amazon, WebEx, Microsoft and more. Badgeville investors are InterWest Partners, Norwest Venture Partners, Trinity Ventures and El Dorado Ventures. To learn more, follow @Badgeville or visit www.badgeville.com.

Tesaro, Inc.

Series B in 2011
Founded in 2010, TESARO is a privately held oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients. The Company intends to leverage the experience and competencies of its management team to identify, acquire and develop promising drug candidates; and to commercialize safer and more effective products for the treatment and support of cancer patients. TESARO is developing rolapitant, a potent, selective neurokinin-1 receptor antagonist that has completed Phase 2 clinical testing for the prevention of chemotherapy induced nausea and vomiting, and is advancing its ALK inhibitor program for oncology indications. Phase 3 clinical testing of rolapitant is planned to commence during 2011 and the first ALK inhibitor clinical trial is targeted to begin in 2012. TESARO was co-founded by former executives of MGI PHARMA, an oncology and acute-care focused biopharmaceutical company that Eisai Co., Ltd. acquired in 2008 for $3.9 billion. TESARO is headquartered in Waltham, Massachusetts.

Drais Pharmaceuticals

Series A in 2012
Drais Pharmaceuticals, Inc. is a venture capital supported drug development company with an exciting new business model. Through strong relationships with Astellas Pharma Inc. and our venture capital investors - InterWest Partners, Sutter Hill Ventures, and Astellas Venture Management LLC, we have created multiple virtual companies to enable the development of interesting novel compounds in a variety of therapeutic areas. Our focus is on early stage development through proof of concept. Our business model relies on a small internal team who provide drug development services to those virtual companies via vendors and CROs. Our internal experts are able to move compounds rapidly through key development milestones and decision points, thus de-risking programs early in development.

AccelChip

Series C in 2005
AccelChip, Inc. provides algorithmic synthesis solutions for digital signal processing (DSP) design. The company develops and markets design tools, integrated verification flows, and parametric intellectual property toolkits that automate the development and implementation of DSP algorithms in field programmable gate-arrays and application-specific integrated circuits. AccelChip, Inc. was formerly known as Mach Design Systems, Inc.

Participate Systems

Series D in 2002
Participate Systems provides outsourced online sales and customer support community solutions. The platform offers self-help solutions, software and management services, monthly and quarterly reports, and operating plans.

Scale Eight

Series D in 2002
Scale Eight is an internet company. It offers virtually limitless storage capacity, allowing companies to grow their online offerings. Scale Eight delivers file storage solutions technology through its global storage service and in a family of network-attached storage products. Scale Eight was founded by Josh Coates and is located in San Francisco, California.

Epocrates

Series C in 2002
Epocrates develops mobile and online clinical information and decision support software that enables health-care professionals to find answers more quickly and confidently at the point of care. 1 out of 3 U.S. physicians and 1 out of 3 U.S. medical students currently use Epocrates software.
PrimeraDx, Inc. offers multiplexed infectious disease assays. It provides Scalable Target Amplification Routine technology, which is a method for simultaneous quantitative measurement of multiple target nucleic acids. The company also offers ViraQuant, a multiplexed assay providing quantitative and simultaneous measurement of viruses; and FungiQuant Yeast and FungiQuant Mold, which are fungal panels for mycology testing. Its products are used in miRNA, DNA methylation, quantitative genotyping, gene expression, and viral load measurement applications. PrimeraDx, Inc. was founded in 2004 and is based in Mansfield, Massachusetts.

Gobiquity, Inc.

Venture Round in 2021
Gobiquity, Inc. provides prescribed mobile health applications for the early detection and prevention of health disorders and chronic diseases. It offers GoCheck Kids, a smartphone app that detects amblyopia risk factors and meets the American Association for Pediatric Ophthalmology and Strabismus guidelines for vision screening in children. Gobiquity, Inc. was formerly known as ICHECK Health Connection, Inc. The company was founded in 2010 and is based in Aliso Viejo, California.

Bivio Networks

Venture Round in 2008
Founded in 2000, Bivio Networks is dedicated to providing leading networking products that enable government agencies and service providers to control, monitor, and secure critical network infrastructure. A leader in cyber intelligence, cyber security and network control solutions, Bivio has deployed its products in a wide range of solutions. Bivio’s global customer base includes leading intelligence agencies, military organizations and service providers. Bivio is privately-held and is headquartered in the San Francisco Bay Area with office locations worldwide. Specialties Cyber Security, Cyber Intelligence, Deep Packet Inspection (DPI) Networking Systems, Mass Metadata Extraction and Analysis, Data Retention System, Cyber Investigation, network probe

Virsto Software

Series B in 2011
Virsto was founded in late 2007 by a team of storage and virtualization experts who saw that the old ways of doing storage were not working in the virtual server era. We believe we are building a visionary storage software platform that will fundamentally transform the data center – decoupling storage from the physical world once and for all to save organizations time and money. Virsto's solutions address the growing need for cost-effective and efficient storage for virtual servers and desktops. Companies around the world use Virsto to achieve increases in performance, reduce storage capital and operating costs, and streamline provisioning and data management for virtual computing.

Right90

Series C in 2008
Right90 is a sales and revenue forecasting software, designed to increase accountability in a company's sales department by actively compiling and analyzing data from different departments within the sales and management branches. Right90, Inc. was founded in 2003 and is headquartered in Foster City, California.

Damballa

Series E in 2014
As the experts in advanced threat protection, Damballa discovers active threats that bypass all security prevention layers. Damballa automatically identifies successful infections and pinpoints devices that represent the highest risk to a business. Our patent-pending solutions combine principles of data science and machine learning to discover threats without prior knowledge of them and regardless of device type, OS and threat vector. Damballa protects nearly a billion endpoints globally at enterprises in every major market and for the world’s largest ISP and telecommunications providers. For more information, visit www.damballa.com, or follow us on Twitter @DamballaInc. Watch an analyst interview with Brian Foster, CTO until June, 2015 , here: https://vimeo.com/129326008

Labrys Biologics

Series A in 2013
Labrys Biologics Inc., a company focused on treatments for chronic migraine. Labrys Biologics has acquired worldwide rights to RN-307 from Pfizer Inc. RN-307 is an antibody for the treatment of chronic migraine.

GAIN Fitness

Seed Round in 2011
GAIN Fitness's web and mobile applications generate personalized training plans based on exercise science, matched to an individual's body, goals, and lifestyle factors, to help regular exercisers optimize fitness and adapt to schedule changes. They motivate exercisers with social tie-ins and game mechanics, and keep things fresh with their custom built database of over 750 exercises. They're partnering with personal trainers and equipment retailers to sell interactive multimedia packs, a la App Store for Fitness.
InVisage Technologies Inc., a fabless semiconductor company, produces quantum dot-based image sensors. The company's product enables the high resolution images from handheld devices, such as camera phones and PDAs. Its products are used in security and surveillance, automotive imaging, military, and medical imaging applications, as well as mobile phone cameras, Webcams, and digital still cameras. The company was incorporated in 2005 and is based in Menlo Park, California.

Broadband Gateways

Venture Round in 2000
Broadband Gateways, developer of an intelligent premises gateway for the broadband voice and data market.

Flurry, Inc.

Series D in 2013
Flurry is an application that provides analytics for businesses to monitor the trends and habits of mobile users across multiple mobile applications. Flurry’s mobile analytics solution enables businesses to understand how consumers interact with their mobile applications. Over 125,000 companies use Flurry’s analytics platform in more than 400,000 applications to measure audience reach, engagement, retention, conversions, revenue, and more. The service is completely free, takes just five minutes for basic integration, and is continuously updated with the industry's advanced features. Flurry Analytics is available for iOS, Android, Windows Phone, HTML5, hybrid apps, mobile/web, Blackberry, and JavaME.

Carwoo

Series A in 2010
Carwoo is an online platform that enables its users to anonymously buy cars from dealers in their local area. Carwoo was launched in 2008 and is based in California.

Gynesonics

Series D in 2013
Gynesonics, Inc. designs and develops minimally invasive solutions for symptomatic uterine fibroids in women. The company offers Sonography-Guided Transcervical Fibroid Ablation (Sonata) System(The Sonata System) for the transcervical treatment of symptomatic uterine fibroids under intrauterine sonography guidance serving customers in the European Union. Gynesonics, Inc. was founded in 2005 and is based in Redwood City, California with an additional location in Beuningen, the Netherlands.

Marketo

Series D in 2010
Marketing automation software

MacroGenics

Venture Round in 2002
MacroGenics, Inc., a biotechnology company, focuses on the development, manufacture, and commercialization of immunotherapeutics for autoimmune disorders, cancer, and infectious diseases. The company is developing immune-based products, including monoclonal antibodies; and vaccines to prevent infections in healthy individuals. The company's Fc engineering technology enables to improve antibody functions to eliminate cancer cells. It is also developing products around the Dual Activating ReTargeting technology. The company was founded in 2000 and is headquartered in Rockville, Maryland.

Flurry, Inc.

Series D in 2012
Flurry is an application that provides analytics for businesses to monitor the trends and habits of mobile users across multiple mobile applications. Flurry’s mobile analytics solution enables businesses to understand how consumers interact with their mobile applications. Over 125,000 companies use Flurry’s analytics platform in more than 400,000 applications to measure audience reach, engagement, retention, conversions, revenue, and more. The service is completely free, takes just five minutes for basic integration, and is continuously updated with the industry's advanced features. Flurry Analytics is available for iOS, Android, Windows Phone, HTML5, hybrid apps, mobile/web, Blackberry, and JavaME.

NeuroPace

Venture Round in 2011
NeuroPace, Inc. designs, develops, manufactures, and markets implantable devices for the treatment of neurological disorders with responsive stimulation. It offers RNS System, a medical device that monitors and responds to brain activity. The company’s RNS System consists of a small implantable neuro stimulator that is connected to leads that are placed in up to two seizure onset areas. NeuroPace, Inc. was founded in 1997 and is based in Mountain View, California.
InVisage Technologies Inc., a fabless semiconductor company, produces quantum dot-based image sensors. The company's product enables the high resolution images from handheld devices, such as camera phones and PDAs. Its products are used in security and surveillance, automotive imaging, military, and medical imaging applications, as well as mobile phone cameras, Webcams, and digital still cameras. The company was incorporated in 2005 and is based in Menlo Park, California.

Apteligent

Series C in 2014
Crittercism, based in San Francisco, California, is the company behind the world’s first mobile application performance management (mAPM) solution. The company’s flagship product monitors every aspect of mobile app performance, allowing Developers, IT Operations and Product Managers to deliver high performing, highly reliable, highly resourceful mobile apps. Crittercism provides a real-time global view of app diagnostics across iOS, Android, Windows Phone 8, Hybrid and HTML5 apps and is used on more than 600 million unique devices and in more than 100 billion app sessions. The company’s investors include Google Ventures, Opus Capital and Shasta Ventures. Crittercism was part of **[AngelPad](http://angelpad.org) #2** in 2011

Restoration Robotics

Venture Round in 2016
Restoration Robotics is a privately held medical device company, is dedicated to revolutionizing the field of hair transplantation by developing and commercializing a state-of-the-art image-guided system (ARTAS™ System) that enables follicular unit extraction.

Nereus Pharmaceuticals

Series D in 2005
Nereus Pharmaceuticals, Inc. engages in the discovery and development of therapeutics for the treatment of oncology, infectious diseases, and inflammation. The company uses its marine microbiology technologies for the discovery and development of drug candidates. Its oncology drug candidates include NPI-2358, a tumor vascular disrupting agent for the treatment of solid tumors; and NPI-0052, a proteasome inhibitor for the treatment of solid tumors, lymphomas, and multiple myeloma. The company was founded in 1998 and is based in San Diego, California.

Brecis Communications

Series C in 2003
BRECIS Communications, a communications company focused on leading-edge, broadband multi-service network processor architectures.

Microfabrica Inc.

Series B in 2008
Microfabrica Inc. designs and develops micro-scale additive manufacturing solutions. The company offers a process that combines 3D printing that enables structures to be built layer by layer. Its process creates objects from layers of metal to produce extremely refined structures. The company also provides minuscule surgical instruments, including biopsy forceps and a tissue scaffold with linkages that allow it to expand with cell growth. It serves to aerospace, electronics, medical devices, and other industries. Microfabrica Inc. was formerly known as MEMGen Corporation and changed its name to Microfabrica Inc. in September 2003. The company was founded in 1999 and is headquartered in Van Nuys, California with an additional office in Santa Clara, California. As of May 20, 2019, Microfabrica Inc. operates as a subsidiary of Technoprobe S.p.A.

Welltok

Series B in 2013
Welltok is a data-driven, enterprise SaaS company that delivers the healthcare industry’s leading consumer activation platform. Welltok’s solutions empower health plans, employers, providers, and public entities to connect consumers with personalized health improvement resources, making it easy and rewarding for consumers to complete actions that optimize their health and wellbeing. The company was founded in 2009 and headquartered in Denver, Colorado.

APT Pharmaceuticals

Series B in 2008
APT Pharmaceuticals is a drug development company focused on repurposing well-characterized drugs for under-served populations. APT’s initial focus is on the pulmonary delivery of treatments for serious lung diseases.

Welltok

Series D in 2015
Welltok is a data-driven, enterprise SaaS company that delivers the healthcare industry’s leading consumer activation platform. Welltok’s solutions empower health plans, employers, providers, and public entities to connect consumers with personalized health improvement resources, making it easy and rewarding for consumers to complete actions that optimize their health and wellbeing. The company was founded in 2009 and headquartered in Denver, Colorado.

Pivot3

Series E in 2014
Global Hyper-Converged Infrastructure

C9 Inc.

Series B in 2009
C9 delivers predictive sales and marketing applications that increase revenue, generate more precise forecasts and mitigate pipeline risk. By combining data science with products that improve sales and marketing execution, C9 enables leading companies like Yahoo!, Pitney Bowes and Google to drive predictable growth. C9 is located in San Mateo and is backed by the Mayfield Fund, InterWest Partners and Leapfrog Ventures.

Get Satisfaction, Inc.

Series B in 2011
Based in San Francisco, Get Satisfaction provides an online community platform connecting companies with customers to foster relationships that unlock new value for both sides. Companies of all sizes and industries—from Kellogg's and P&G to [Sonos](/organization/sonos), [HootSuite](/organization/hootsuite) and [SugarCRM](/organization/sugarcrm)—rely on Get Satisfaction to deliver online communities that modernize customer support, accelerate sales, differentiate their brand and inspire new innovations. Get Satisfaction's community platform offers the fastest time to value for companies ready to embrace the way today’s customers want to engage.

Brand.net

Series B in 2008
Brand.net is an online advertising network focused exclusively on brand advertising. Their technology is designed to allow Brand advertisers and agencies to reach the right target in the right context, efficiently and measurably.

Spredfast

Series D in 2014
Spredfast, Inc. provides a social relationship platform that allows enterprise brands and organizations to manage, monitor, and measure their social media programs in the United States and internationally. The company was formerly known as Social Agency, Inc. and changed its name to Spredfast, Inc. in January 2010. Spredfast, Inc. was founded in 2008 and is based in Austin, Texas with an additional office in London, United Kingdom. As of October 2, 2018, Spredfast, Inc. operates as a subsidiary of Lithium Technologies Inc.

Damballa

Series D in 2011
As the experts in advanced threat protection, Damballa discovers active threats that bypass all security prevention layers. Damballa automatically identifies successful infections and pinpoints devices that represent the highest risk to a business. Our patent-pending solutions combine principles of data science and machine learning to discover threats without prior knowledge of them and regardless of device type, OS and threat vector. Damballa protects nearly a billion endpoints globally at enterprises in every major market and for the world’s largest ISP and telecommunications providers. For more information, visit www.damballa.com, or follow us on Twitter @DamballaInc. Watch an analyst interview with Brian Foster, CTO until June, 2015 , here: https://vimeo.com/129326008

Achates Power, Inc.

Series A in 2009
Achates Power specializes in the fields of combustion engine development, clean diesel, and 2-stroke oil control management. The company is on a mission to build better, more efficient engines, the company has an experienced staff of engineers and scientists focused on applying their proven technical know-how and expertise, coupled with the industry's leading-edge testing, simulation, and analysis tools. it was founded in 2004 and headquartered in San Diego, California.

Totango Ltd.

Series D in 2018
Totango, Inc. develops an enterprise grade customer success platform that allows users to connect their customers’ data, monitor health changes, and engage their customers. The company offers Customer Success Centre, a solution for customer engagement; Zoe, a solution for enterprise impact; and DNA-CX, a solution for multidimensional customer context in real-time. Its solutions include voice of the customer, customer onboarding, customer adoption, customer renewal, and customer escalation. The company was founded in 2010 and is based in Redwood City, California. Totango, Inc. operates as a subsidiary of Totango Ltd.

Spredfast

Series F in 2016
Spredfast, Inc. provides a social relationship platform that allows enterprise brands and organizations to manage, monitor, and measure their social media programs in the United States and internationally. The company was formerly known as Social Agency, Inc. and changed its name to Spredfast, Inc. in January 2010. Spredfast, Inc. was founded in 2008 and is based in Austin, Texas with an additional office in London, United Kingdom. As of October 2, 2018, Spredfast, Inc. operates as a subsidiary of Lithium Technologies Inc.

Pelican Imaging

Series C in 2013
Pelican Imaging Corporation is a venture-backed software start-up in the business of commercializing computational cameras for the smartphone market. The company is developing a new camera technology that directly addresses the challenges posed by conventional camera design and small pixels. Investors include Globespan Capital Partners, Granite Ventures, InterWest Partners, and IQT.
Centrexion Therapeutics is focused on developing new therapies for moderate to severe chronic pain that address the safety and efficacy gaps in the current treatment paradigm.We aim to relieve the suffering associated with chronic pain by creating treatments that address the safety and efficacy gaps in the current treatment paradigm.

Wiser Solutions

Series A in 2015
Wiser is the leading provider of actionable data for better decisions. Wiser collects and analyzes online and in-store data with unmatched speed, scale and accuracy. The Wiser platform then blends these insights with advanced workflow software to drive business value for brands and retailers. Using a unique combination of data science and human validation, Wiser offers integrated solutions for every aspect of retail, all in one place.

Nuventix

Venture Round in 2011
Nuventix is an active thermal management solutions company located in Austin, Texas. The Nuventix-developed SynJet® module is a newly patented synthetic jet cooling technology that utilizes turbulent pulses of air generated from an electromagnetic actuator. Based on early success with computer cooling, Nuventix's innovative approach to LED cooling is propelling that market forward two years ahead of analyst estimates - truly affecting the industry and allowing general illumination designs to harvest the efficiencies of the LED.

NewsCred

Series D in 2015
NewsCred, the global leader in enterprise content marketing, empowers the world’s most ambitious brands with powerful technology, the largest and most diverse content offerings, and proven, unrivaled expertise. Through its complete solution, NewsCred offers a repeatable methodology that guarantees ROI for the world’s leading CMOs and marketing leaders from companies including Barclays, Cox Communications, Fidelity, HPE, USAA, Virgin Media, and more. Founded in 2008, NewsCred serves hundreds of customers in over 70 countries from seven global offices. Learn more at NewsCred.com, join our community at NewsCred Insights and follow us on Twitter and LinkedIn.
Advanced Micro-Fabrication Equipment Inc. (中微半导体设备(上海)有限公司) is a Chinese global microfabrication equipment company serving customers in the semiconductor industry and relevant high-tech sectors. The company is a specialized supplier of key equipment for the production and development of micron-sized and nanoscale VLSI for the semiconductor industry in China and Asia. The company is focused on chemical vapor deposition and plasma etching products.

AppMesh

Seed Round in 2012
AppMesh is building the next generation business platform for mobile devices. Founded by salesforce.com veterans, we believe that in the post-PC era business applications need to be personal, seamless, and intuitive.

Tasman Networks

Venture Round in 1999
Tasman Networks is a manufacturer of Multi-service edge router.

MacroGenics

Series A in 2001
MacroGenics, Inc., a biotechnology company, focuses on the development, manufacture, and commercialization of immunotherapeutics for autoimmune disorders, cancer, and infectious diseases. The company is developing immune-based products, including monoclonal antibodies; and vaccines to prevent infections in healthy individuals. The company's Fc engineering technology enables to improve antibody functions to eliminate cancer cells. It is also developing products around the Dual Activating ReTargeting technology. The company was founded in 2000 and is headquartered in Rockville, Maryland.

Aria Systems, Inc.

Private Equity Round in 2018
Proven by the world's most demanding enterprises, including AAA NCNU, Constant Contact, Falck, Hootsuite, Pitney Bowes, Audi, Adobe, Telekom Denmark, Philips, Roku, and VMware, Aria helps enterprises grow their recurring revenue businesses. Aria helps clients take advantage of each customer-driven event − known as revenue moments − with agile billing, active customer engagement, and the rapid development of new products and services. With Aria's end-to-end active monetization platform, global brands can get to market faster with a wider variety of products and services, while maximizing customer satisfaction, retention, and lifetime value.

SignalDemand

Venture Round in 2008
SignalDemand delivers margin optimization software that enables process manufacturers to maximize profitability, even as costs and markets change around them. The company's applications rely on the latest econometric models, optimization algorithms and activity-based costing techniques.

LongBoard

Series C in 2002
LongBoard, Inc. provides software solutions to enable the telecommunications carriers and service providers to deliver converged multimedia services. Its products include MediaRoam that provides telecommunications carriers with the ability to deliver differentiated Initiation Protocol Multimedia Subsystem enabled multimedia services across fixed and mobile networks; LongBoard Multimedia Application Platform, which provides a carrier-class software infrastructure for integrating IP-based communications; and OnePhone, a personal mobility application that automatically and transparently switches calls between cellular and WiFi networks. LongBoard, Inc. was formerly known as Persona Software, Inc. and it changed its name to LongBoard, Inc. in February 2006. The company was founded in 1999 and is based in Santa Clara, California with sales offices in London, the United Kingdom and Tokyo, Japan.

Neuronetics

Series G in 2017
Neuronetics is focused on developing non-invasive therapies for psychiatric and neurological disorders using MRI-strength magnetic field pulses. They are the first and only company to have a non-systemic and non-invasive depression treatment cleared by the FDA for patients who have not benefited from prior antidepressant treatment. The company was founded in 2003 and is based in Malvern, Pennsylvania.

Staccato Communications

Venture Round in 2008
Staccato Communications, Inc. offers ultra wideband wireless enabled devices for the wireless USB, Bluetooth, and Internet protocol connectivity to the personal computing, consumer electronics, and mobile phone industries. Its products include single-chip integrated circuits, device adapter and device module design kits, reference design kits, wireless USB development kits, and streaming services development kits. The company also provides Ripcord Software, which provides a software stack for variety of ultra wide band applications, as well as includes installers, firmware, middleware, drivers, customization tools, and firmware upgrade tools. Staccato Communications’ products are used in various applications, such as printers, camera, mass storage devices, portable media players, wireless docking, wireless projectors, Web cameras, wireless HDTV, wireless speakers, set top boxes, wireless displays, purchasing content, sharing content, and personal servers. Staccato Communications, Inc. was formerly known as Discrete Time Communications, Inc. The company was founded in 2002 and is based in San Diego, California.

CardioMind

Series B in 2004
CardioMind, Inc. Inc manufactures therapeutic devices for cardiovascular diseases. The company also offers stent delivery systems, which are designed for use in lesion applications, as well as for the treatment of coronary and peripheral artery diseases. In addition, it provides invasive endovascular medical devices for treating neurological and cardiovascular diseases. The company was founded in 2003 and is based in Sunnyvale, California.

Gear6

Series C in 2006
Gear6 sells Memcached solutions enabling high-growth web sites to deliver and scale dynamic applications and content. By focusing on the emerging need for a dedicated web caching tier, Gear6 solutions improve the scalability of web applications and databases, improving quality of service and reducing infrastructure cost.

Epocrates

Series B in 2000
Epocrates develops mobile and online clinical information and decision support software that enables health-care professionals to find answers more quickly and confidently at the point of care. 1 out of 3 U.S. physicians and 1 out of 3 U.S. medical students currently use Epocrates software.

C9 Inc.

Series D in 2013
C9 delivers predictive sales and marketing applications that increase revenue, generate more precise forecasts and mitigate pipeline risk. By combining data science with products that improve sales and marketing execution, C9 enables leading companies like Yahoo!, Pitney Bowes and Google to drive predictable growth. C9 is located in San Mateo and is backed by the Mayfield Fund, InterWest Partners and Leapfrog Ventures.
Advanced Micro-Fabrication Equipment Inc. (中微半导体设备(上海)有限公司) is a Chinese global microfabrication equipment company serving customers in the semiconductor industry and relevant high-tech sectors. The company is a specialized supplier of key equipment for the production and development of micron-sized and nanoscale VLSI for the semiconductor industry in China and Asia. The company is focused on chemical vapor deposition and plasma etching products.

Diatos

Series D in 2007
Diatos is a biopharmaceutical company founded in 1999 and headquartered in Paris, France with two subsidiaries in Leuven, Belgium and in the San Francisco Bay Area, USA. Diatos is focused on the research, development and marketing of new versions of existing anti-cancer chemotherapeutic drugs with enhanced tumor targeting or improved biodistribution. Diatos has built its portfolio of drugs and drug candidates through a strategy of license acquisitions as well as an internal research and development activity based on its prodrug technologies, Vectocell® and Tumor-Selective Prodrug (TSP).

SpectraLinear

Series B in 2006
SpectraLinear, Inc., a fabless mixed signal IC company, designs, develops, manufactures, and markets timing circuits. The company's products include computer clocks, buffers, zero delay buffers, EMI reduction circuits, and systems clocks for the consumer and PC clock applications. Its products enable various electronic applications, such as digital television, high definition digital television, digital still camera, digital movie camera or camcorders, set-top box, multi function printers, laser and inkjet printers, copiers, notebook and desktop computers, servers, and communication systems, as well as automotive, gaming, cash registers, and other industrial applications. The company serves consumer, computer, and communication markets. It has locations in Istanbul, Turkey; Bangalore, India; Taiwan; and Japan. SpectraLinear, Inc. was founded in 2006 and is based in Santa Clara, California.

Satori Pharmaceuticals

Series B in 2011
Satori Pharmaceuticals is a neuroscience company focused on the discovery and development of disease-modifying therapies for Alzheimer's disease, Parkinson's disease and other neurodegenerative disorders.

CubeTree

Series B in 2009
CubeTree offers a full-featured enterprise collaboration suite built on an enterprise social networking platform. Companies can create private, secure enterprise social networks using CubeTree. By leveraging features which people already use in the consumer world – like user profiles, micro-blogging, follow/following news feeds and groups at CubeTree makes it easier for employees to understand and fully utilize the system. A full suite of collaboration tools is tightly integrated with CubeTree’s enterprise social networking platform, and includes wikis, blogs, polls, file sharing, link sharing, search and more. CubeTree has pre-built integrations to many consumer and enterprise products including Twitter®, Google Docs and Google Reader, Salesforce.com, WebEx and Basecamp. The standard version is free for unlimited users, allowing anyone to create a network for their company and invite colleagues to join. Premium versions offer additional features and storage.

Wiser Solutions

Venture Round in 2016
Wiser is the leading provider of actionable data for better decisions. Wiser collects and analyzes online and in-store data with unmatched speed, scale and accuracy. The Wiser platform then blends these insights with advanced workflow software to drive business value for brands and retailers. Using a unique combination of data science and human validation, Wiser offers integrated solutions for every aspect of retail, all in one place.

Brand.net

Series A in 2007
Brand.net is an online advertising network focused exclusively on brand advertising. Their technology is designed to allow Brand advertisers and agencies to reach the right target in the right context, efficiently and measurably.

SpectraLinear

Series A in 2006
SpectraLinear, Inc., a fabless mixed signal IC company, designs, develops, manufactures, and markets timing circuits. The company's products include computer clocks, buffers, zero delay buffers, EMI reduction circuits, and systems clocks for the consumer and PC clock applications. Its products enable various electronic applications, such as digital television, high definition digital television, digital still camera, digital movie camera or camcorders, set-top box, multi function printers, laser and inkjet printers, copiers, notebook and desktop computers, servers, and communication systems, as well as automotive, gaming, cash registers, and other industrial applications. The company serves consumer, computer, and communication markets. It has locations in Istanbul, Turkey; Bangalore, India; Taiwan; and Japan. SpectraLinear, Inc. was founded in 2006 and is based in Santa Clara, California.

Ribbon Payments, Inc.

Pre Seed Round in 2011
Ribbon Payments, Inc. operates a platform that allows users to sell and purchase products by sharing a unique showcase link. The company supports various types of products from physical and digital goods to services, such as T-shirts, mp3s, and tutoring products. It process debit and credit cards for payments. Ribbon Payments, Inc. was formerly known as Kout Inc. and changed its name to Ribbon Payments, Inc. in November 2012. The company was incorporated in 2011 and is based in San Francisco, California.

Trius Therapeutics

Series A in 2007
Trius Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics for life-threatening infections. We have successfully completed two Phase 3 clinical trials for Tedizolid Phosphate (TR-701), formerly torezolid phosphate, in ABSSSI. Tedizolid is an IV and orally administered second generation oxazolidinone, for the treatment of serious gram-positive bacterial infections, including those caused by methicillin-resistant Staphylococcus aureus (MRSA). With the continuous increase in bacterial resistance to currently marketed drugs, serious infections are becoming more difficult, if not impossible to treat, and this has led to a clear need for novel therapeutics to treat multi-drug resistant bacterial infections. Trius is headquartered in San Diego, California. We have built a strong management team with significant development and regulatory experience. Our senior management team consists of nine individuals who collectively have been involved in the development and approval of a significant number of anti-infective drugs.
INVIDI Technologies Corporation provides software applications that track targeted advertising. It offers Advatar, a digital set-top box application that delivers addressable targeted advertising and marketing messages to individual viewers. It facilitates the sales of digital products, digital tiers, and digital services, such as VOD, PVR, and pay-per-view events; Internet, voice, and wireless services; and triple play offers. Advatar serves multi-channel video programming distributors, marketers, advertisers, and media buyers and sellers. The company also provides INVIDI Advertising Decision System, an addressable television advertising technology for managing advertising decisions and selections for household delivery in the evolving business of television advertising. INVIDI Technologies Corporation was founded in 2000 and is headquartered in Princeton, New Jersey.

Neuronetics

Series B in 2005
Neuronetics is focused on developing non-invasive therapies for psychiatric and neurological disorders using MRI-strength magnetic field pulses. They are the first and only company to have a non-systemic and non-invasive depression treatment cleared by the FDA for patients who have not benefited from prior antidepressant treatment. The company was founded in 2003 and is based in Malvern, Pennsylvania.

Cuyana

Venture Round in 2015
Cuyana is an online fashion brand that believes in fewer, better things. It creates apparel and accessories, designed with a classic, modern aesthetic, sourced from the world's highest quality materials and crafted to last a lifetime. By selling directly to customers rather than through other retailers, Cuyana is able to offer high-quality, timeless pieces at attainable prices. Cyana was founded in 2013 and is based in San Francisco, California.

MacroGenics

Series B in 2004
MacroGenics, Inc., a biotechnology company, focuses on the development, manufacture, and commercialization of immunotherapeutics for autoimmune disorders, cancer, and infectious diseases. The company is developing immune-based products, including monoclonal antibodies; and vaccines to prevent infections in healthy individuals. The company's Fc engineering technology enables to improve antibody functions to eliminate cancer cells. It is also developing products around the Dual Activating ReTargeting technology. The company was founded in 2000 and is headquartered in Rockville, Maryland.

BioMimetic Therapeutics

Series C in 2004
BioMimetic Therapeutics is a biotechnology company that develops products to help stimulate the body natural tissue regenerative process. The company's products and product candidates include Augment Injectable and Augment Rotator Cuff for several orthopedic and sports medicine indications comprising the treatment of foot and ankle fusions, the stimulation of wrist fracture healing, and the surgical treatment of rotator cuff tears, as well as Augment Tendinopathy Injection for injuries cause of tendon overuse. BioMimetic Therapeutics was founded on 1999 and is headquartered in Franklin, Tennessee.

Neuronetics

Series A in 2003
Neuronetics is focused on developing non-invasive therapies for psychiatric and neurological disorders using MRI-strength magnetic field pulses. They are the first and only company to have a non-systemic and non-invasive depression treatment cleared by the FDA for patients who have not benefited from prior antidepressant treatment. The company was founded in 2003 and is based in Malvern, Pennsylvania.

Celladon

Post in 2015
Celladon Corporation, a biotechnology company, develops and manufactures molecular therapies for the treatment of heart failure. Its products include SERCA2a, an enzyme that regulates calcium cycling and contractility in heart muscle cells; and MYDICAR, an enzyme replacement therapy for heart failure. Celladon was founded in 2000 and is based in La Jolla, California.
INVIDI Technologies Corporation provides software applications that track targeted advertising. It offers Advatar, a digital set-top box application that delivers addressable targeted advertising and marketing messages to individual viewers. It facilitates the sales of digital products, digital tiers, and digital services, such as VOD, PVR, and pay-per-view events; Internet, voice, and wireless services; and triple play offers. Advatar serves multi-channel video programming distributors, marketers, advertisers, and media buyers and sellers. The company also provides INVIDI Advertising Decision System, an addressable television advertising technology for managing advertising decisions and selections for household delivery in the evolving business of television advertising. INVIDI Technologies Corporation was founded in 2000 and is headquartered in Princeton, New Jersey.
QuatRx Pharmaceuticals Company, a biopharmaceutical company, engages in discovering, licensing, developing, and commercializing compounds in the areas of endocrine, metabolic, and cardiovascular therapeutics. Its products include Osphena for the treatment for vaginal atrophy, a common problem associated with estrogen deficiency in post-menopausal women. QuatRx Pharmaceuticals Company was founded in 2000 and is based in Ann Arbor, Michigan.

Platform Solutions

Series B in 2004
Platform Solutions, Inc. develops Open Mainframe computers compatible with a set of datacenter environments and operating systems. It offers Open Mainframe servers, Open Systems servers, and NEC D-Series storage arrays. The company's System64 product line consolidates z/OS, Windows, and Linux operating system in one secure and reliable operating environment based on Intel Itanium 2 processor technology. Platform Solutions has a strategic partnership with T3 Technologies. The company was founded in 1999 and is based in Sunnyvale, California. As of June 30, 2008, Platform Solutions, Inc. operates as a subsidiary of International Business Machines Corp.

Braze

Series D in 2017
Braze is a comprehensive customer engagement platform that powers relevant and memorable experiences between consumers and the brands they love. Context underpins every Braze interaction, helping brands foster human connection with consumers through interactive conversations across channels that deliver value quickly and continuously. The company was named a Leader in the 2019 Gartner Magic Quadrant for Mobile Marketing Platforms and was recognized as one of Inc Magazine's 2019 Best Workplaces. Braze is headquartered in New York with offices in Chicago, London, San Francisco, and Singapore. Learn more at braze.com.

Doximity

Series B in 2012
Founded in 2011, Doximity connects physicians and clinicians to make them more successful and productive. It is the largest professional medical network with over 70 percent of all U.S. physicians as members. The network enables medical professionals to communicate with colleagues and patients, and to share their perspectives on the latest health care trends and research. Doximity is based in San Francisco and was created by the founders of Epocrates and Rock Health. To learn more, visit www.doximity.com

Cebix

Venture Round in 2010
Cebix is focused on the development of chronic replacement therapy based on human proinsulin C-peptide for the treatment of type 1 diabetic neuropathy. The role of C-peptide will also be explored in type 1 diabetic nephropathy and retinopathy.

Gobiquity, Inc.

Series B in 2016
Gobiquity, Inc. provides prescribed mobile health applications for the early detection and prevention of health disorders and chronic diseases. It offers GoCheck Kids, a smartphone app that detects amblyopia risk factors and meets the American Association for Pediatric Ophthalmology and Strabismus guidelines for vision screening in children. Gobiquity, Inc. was formerly known as ICHECK Health Connection, Inc. The company was founded in 2010 and is based in Aliso Viejo, California.

Myogen

Series D in 2001
Myogen is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics for the treatment of cardiovascular disorders. They believe that our advanced understanding of the biology of cardiovascular disease combined with their clinical development expertise in cardiovascular therapeutics provide us with the capability to discover novel therapies, as well as identify, license or acquire products that address serious, debilitating cardiovascular disorders that are not adequately treated with existing therapies.

Tesaro, Inc.

Post in 2016
Founded in 2010, TESARO is a privately held oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients. The Company intends to leverage the experience and competencies of its management team to identify, acquire and develop promising drug candidates; and to commercialize safer and more effective products for the treatment and support of cancer patients. TESARO is developing rolapitant, a potent, selective neurokinin-1 receptor antagonist that has completed Phase 2 clinical testing for the prevention of chemotherapy induced nausea and vomiting, and is advancing its ALK inhibitor program for oncology indications. Phase 3 clinical testing of rolapitant is planned to commence during 2011 and the first ALK inhibitor clinical trial is targeted to begin in 2012. TESARO was co-founded by former executives of MGI PHARMA, an oncology and acute-care focused biopharmaceutical company that Eisai Co., Ltd. acquired in 2008 for $3.9 billion. TESARO is headquartered in Waltham, Massachusetts.

Covaro Networks

Series A in 2002
Covaro Networks develops telecommunications products for converged networks, enabling network infrastructure providers to unlock stranded profits while using high bandwidth services and containing capital and operating expenditures.

Pivot3

Venture Round in 2013
Global Hyper-Converged Infrastructure

Spredfast

Series C in 2013
Spredfast, Inc. provides a social relationship platform that allows enterprise brands and organizations to manage, monitor, and measure their social media programs in the United States and internationally. The company was formerly known as Social Agency, Inc. and changed its name to Spredfast, Inc. in January 2010. Spredfast, Inc. was founded in 2008 and is based in Austin, Texas with an additional office in London, United Kingdom. As of October 2, 2018, Spredfast, Inc. operates as a subsidiary of Lithium Technologies Inc.

Pivot3

Series C in 2008
Global Hyper-Converged Infrastructure
Aspreva Pharmaceuticals Corp is an emerging pharmaceutical company headquartered in Victoria, British Columbia focused on identifying, developing and commercializing new indications for approved drugs and drug candidates for underserved patient populations. Their strategy, which they call “indication partnering”, is to collaborate with pharmaceutical and biopharmaceutical companies to pursue new indication approvals which lie beyond their strategic focus.
QuatRx Pharmaceuticals Company, a biopharmaceutical company, engages in discovering, licensing, developing, and commercializing compounds in the areas of endocrine, metabolic, and cardiovascular therapeutics. Its products include Osphena for the treatment for vaginal atrophy, a common problem associated with estrogen deficiency in post-menopausal women. QuatRx Pharmaceuticals Company was founded in 2000 and is based in Ann Arbor, Michigan.
INVIDI Technologies Corporation provides software applications that track targeted advertising. It offers Advatar, a digital set-top box application that delivers addressable targeted advertising and marketing messages to individual viewers. It facilitates the sales of digital products, digital tiers, and digital services, such as VOD, PVR, and pay-per-view events; Internet, voice, and wireless services; and triple play offers. Advatar serves multi-channel video programming distributors, marketers, advertisers, and media buyers and sellers. The company also provides INVIDI Advertising Decision System, an addressable television advertising technology for managing advertising decisions and selections for household delivery in the evolving business of television advertising. INVIDI Technologies Corporation was founded in 2000 and is headquartered in Princeton, New Jersey.

Spredfast

Series B in 2011
Spredfast, Inc. provides a social relationship platform that allows enterprise brands and organizations to manage, monitor, and measure their social media programs in the United States and internationally. The company was formerly known as Social Agency, Inc. and changed its name to Spredfast, Inc. in January 2010. Spredfast, Inc. was founded in 2008 and is based in Austin, Texas with an additional office in London, United Kingdom. As of October 2, 2018, Spredfast, Inc. operates as a subsidiary of Lithium Technologies Inc.

Concept.io

Series A in 2013
Concept.io is the creator of Swell Radio, a delightful mobile app that streams personalized audio news and information. Swell helps users discover new content and expand their minds on the go. Concept.io strives to connect people with ideas and knowledge efficiently so we can all be more productive with our time. Concept.io is a technology startup funded by top-tier venture firms. The founding team consists of experienced entrepreneurs with a successful track record.

Avera Pharmaceutical

Series B in 2003
Avera Pharmaceuticals is a specialty pharmaceutical company that acquires, develops, and commercializes pharmaceutical compounds. The company develops gantacurium, a neuromuscular blocking agent for rapid and routine endotracheal intubation and skeletal muscle relaxation during surgery; AV810 for the treatment of overactive bladder and irritable bowel syndrome; and AV965 to treat cognitive impairment associated with schizophrenia and Alzheimer’s dementia. The company was founded in 2002 and is headquartered in San Diego, California.